Skip to main content

Advertisement

Log in

Identifying oncological emergencies

  • Review Article
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Prompt identification and treatment of life-threatening oncological conditions is of utmost importance and should always be included in the differential diagnosis. Oncological emergencies can have a myriad of presentations ranging from mechanical obstruction due to tumor growth to metabolic conditions due to abnormal secretions from the tumor. Notably, hematologic and infectious conditions may complicate the presentation of oncological emergencies. Advanced testing and imaging is generally required to recognize these serious presentations of common malignancies. Early diagnosis and treatment of these conditions can significantly affect the patient’s clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yim CD, Sane SS, Bjarnason H. Superior vena cava stenting. Radiol Clin North Am. 2000;38(2):409–24.

    Article  CAS  PubMed  Google Scholar 

  2. Abrahm JL. Management of pain and spinal cord compression in patients with advanced cancer. ACP–ASIM End-of-life care consensus panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med. 1999;131(1):37–46.

    Article  CAS  PubMed  Google Scholar 

  3. Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349(7):684–90. doi:10.1056/NEJMra022643.

    Article  PubMed  Google Scholar 

  4. Allen KB, Faber LP, Warren WH, Shaar CJ. Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage. Ann Thorac Surg. 1999;67(2):437–40.

    Article  CAS  PubMed  Google Scholar 

  5. Georghiou GP, Stamler A, Sharoni E, Fichman-Horn S, Berman M, Vidne BA, et al. Video-assisted thoracoscopic pericardial window for diagnosis and management of pericardial effusions. Ann Thorac Surg. 2005;80(2):607–10. doi:10.1016/j.athoracsur.2005.02.068.

    Article  PubMed  Google Scholar 

  6. Colman RW, Rubin RN. Disseminated intravascular coagulation due to malignancy. Semin Oncol. 1990;17(2):172–86.

    CAS  PubMed  Google Scholar 

  7. Sarris AH, Kempin S, Berman E, Michaeli J, Little C, Andreeff M, et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood. 1992;79(5):1305–10.

    CAS  PubMed  Google Scholar 

  8. Bick RL. Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin North Am. 2003;17(1):149–76.

    Article  PubMed  Google Scholar 

  9. Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini E, Passerini CG, et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood. 1998;92(1):143–51.

    CAS  PubMed  Google Scholar 

  10. Coiffier B, Mounier N, Bologna S, Ferme C, Tilly H, Sonet A, et al. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin’s lymphoma: results of the GRAAL1 (Groupe d’Etude des lymphomes de l’adulte trial on rasburicase activity in adult lymphoma) study. J Clin Oncol. 2003;21(23):4402–6. doi:10.1200/JCO.2003.04.115.

    Article  CAS  PubMed  Google Scholar 

  11. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;52(4):427–31. doi:10.1093/cid/ciq147.

    Article  Google Scholar 

  12. Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med. 1975;135(5):715–9.

    Article  CAS  PubMed  Google Scholar 

  13. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis Off Publ Infect Dis Soc Am. 2002;34(6):730–51. doi:10.1086/339215.

    Article  Google Scholar 

  14. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;49(1):1–45. doi:10.1086/599376.

    Article  CAS  Google Scholar 

  15. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;52(4):e56–93. doi:10.1093/cid/cir073.

    Article  Google Scholar 

  16. Flynn PM, Van Hooser B, Gigliotti F. Atypical mycobacterial infections of Hickman catheter exit sites. Pediatr Infect Dis J. 1988;7(7):510–3.

    Article  CAS  PubMed  Google Scholar 

  17. Allen U, Smith CR, Prober CG. The value of skin biopsies in febrile, neutropenic, immunocompromised children. Am J Dis Child. 1986;140(5):459–61.

    CAS  PubMed  Google Scholar 

  18. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18(16):3038–51.

    CAS  PubMed  Google Scholar 

  19. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR Recommendations and reports : morbidity and mortality weekly report recommendations and reports/Centers for Disease Control. 1995;44(RR-12):1–13.

  20. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Off Publ Infect Dis Soc Am. 1992;14(6):1201–7.

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Achuta K. Guddati.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guddati, A.K., Kumar, N., Segon, A. et al. Identifying oncological emergencies. Med Oncol 30, 669 (2013). https://doi.org/10.1007/s12032-013-0669-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0669-6

Keywords

Navigation